A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease | MicrobiomeTrials← Back to trialsNCT07326709
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-03-24Est. Completion: 2030-04-02
Enrollment target: 770 participants Locations- CenExcel Rocky Mtn Clin Research, Englewood, Colorado, United States
- Georgetown University, Washington D.C., District of Columbia, United States
- Albany Medical College, Albany, New York, United States
- UBMD Neurology, Buffalo, New York, United States
- Cleveland Clinic Foundation, Cleveland, Ohio, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
- TX Movement Disorder Spec PLLC, Georgetown, Texas, United States
- U of TX Health Science Ct, Houston, Texas, United States
- University of Washington Medical Center, Seattle, Washington, United States
- North York General Hospital, North York, Ontario, Canada
- Centre de recherche du CHUM, Montreal, Quebec, Canada
- CUSM Montreal Neurological Institute, Montreal, Quebec, Canada
- Novartis Investigative Site, Tel Aviv, Israel
- Novartis Investigative Site, Seoul, Seoul, South Korea
- Novartis Investigative Site, Taipei, Taiwan
- Novartis Investigative Site, Aberdeen, Grampian Region, United Kingdom
Other microbiome trials you might be interested in
Lumbar Spinal Stenosis
This prospective longitudinal study will compare incidence rates of Medicare beneficiary surgical and minimally invasive…
Athens, United StatesEst. completion Dec 2026
Diabetes Mellitus, Type 2HypertensionCardiovascular Diseases
This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the …
Anniston, United StatesEst. completion Dec 14, 2029
Novartis Investigative Site, Cardiff, United KingdomNovartis Investigative Site, Glasgow, United KingdomUniversity College Hospital, London, United KingdomSouthampton General Hospital, Southampton, United KingdomRecruiting
This study is a prospective, multicenter, randomized controlled trial of the FlowTriever System plus anticoagulation com…
Birmingham, United StatesEst. completion Jul 2026